, Lancet, vol.375, pp.924-937, 2010.
The acute hepatic porphyrias: current status and future challenges, Best Pract Res Clin Gastroenterol, vol.24, pp.593-605, 2010. ,
The incidence of inherited porphyrias in Europe, J Inherit Metab Dis, vol.36, pp.849-857, 2013. ,
Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France, J Intern Med, vol.242, pp.213-217, 1997. ,
Acute intermittent porphyria, Best Pract Res Clin Gastroenterol, vol.19, pp.235-249, 2005. ,
Recommendations for the diagnosis and treatment of the acute porphyrias, Ann Intern Med, vol.142, pp.439-450, 2005. ,
Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors, J Hepatol, vol.32, pp.933-939, 2000. ,
Acute hepatic porphyrias and primary liver cancer, N Engl J Med, vol.338, pp.1853-1854, 1998. ,
Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up, J Clin Pathol, vol.65, pp.976-980, 2012. ,
Renal symptomatology in patients with acute intermittent porphyria. A population-based study, J Intern Med, vol.248, pp.319-325, 2000. ,
Acute intermittent porphyria and chronic renal failure, Clin Nephrol, vol.69, pp.339-346, 2008. ,
Hypertension and renal disease in patients with acute intermittent porphyria, J Intern Med, vol.236, pp.169-175, 1994. ,
Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and endstage renal disease under different therapy regimes, Cell Mol Biol, vol.55, pp.66-71, 2009. ,
CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES), Am J Kidney Dis, vol.53, pp.46-55, 2009. ,
Measured and estimated GFR in healthy potential kidney donors, Am J Kidney Dis, vol.43, pp.112-119, 2004. ,
Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients, J Am Soc Nephrol, vol.22, pp.1375-1381, 2011. ,
Early epithelial phenotypic changes predict graft fibrosis, J Am Soc Nephrol, vol.19, pp.1584-1591, 2008. ,
Urinary excretion of porphyrins, porphobilinogen and delta-aminolaevulinic acid following an attack of acute intermittent porphyria, J Clin Pathol, vol.67, pp.60-65, 2014. ,
Cell death assays for drug discovery, Nat Rev Drug Discov, vol.10, pp.221-237, 2011. ,
Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death, Am J Transplant, vol.8, pp.2283-2296, 2008. ,
Complex networks orchestrate epithelialmesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, pp.131-142, 2006. ,
The intrarenal vascular lesions associated with primary antiphospholipid syndrome, J Am Soc Nephrol, vol.10, pp.507-518, 1999. ,
Pilot in vitro toxicity study of 5-ALA and Photofrin in microvascular endothelial cell cultures, J Clin Laser Med Surg, vol.15, pp.83-87, 1997. ,
Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall, J Photochem Photobiol B, vol.126, pp.26-32, 2013. ,
Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina?, J Intern Med, vol.247, pp.407-409, 2000. ,
Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria, Ann Intern Med, vol.123, pp.598-600, 1995. ,
Blindness of cerebral origin in acute intermittent porphyria, Arch Neurol, vol.34, pp.310-312, 1977. ,
MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria, Neuroradiology, vol.44, pp.839-841, 2002. ,
Reversible MRI findings of porphyric encephalopathy. A report of two cases, Neuroradiol J, vol.21, pp.655-659, 2008. ,
Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria, Nat Genet, vol.12, pp.195-199, 1996. ,
Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse, PLoS One, vol.7, p.32978, 2012. ,
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans, J Clin Invest, vol.120, pp.4065-4076, 2010. ,
Delta-aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines, BMC Cancer, vol.2, p.6, 2002. ,
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling, J Biol Chem, vol.280, pp.12239-12245, 2005. ,
A2B adenosine receptor-mediated induction of IL-6 promotes CKD, J Am Soc Nephrol, vol.22, pp.890-901, 2011. ,
Interleukin 6 underlies angiotensin IIinduced hypertension and chronic renal damage, Hypertension, vol.59, pp.136-144, 2012. ,
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling, Cell, vol.155, pp.384-396, 2013. ,
Establishing a network of specialist Porphyria centres -effects on diagnostic activities and services, Orphanet J Rare Dis, vol.7, p.93, 2012. ,
Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria, Am J Hum Genet, vol.60, pp.1373-1383, 1997. ,
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo, J Clin Invest, vol.111, pp.515-527, 2003. ,
Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability, Kidney Int, vol.67, pp.2422-2433, 2005. ,
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, vol.25, pp.402-408, 2001. ,
Caspase activation regulates the extracellular export of autophagic vacuoles, Autophagy, vol.8, pp.927-937, 2012. ,